Cortex Pharmaceutic Stock Working Capital
| PHXDelisted Stock | USD 4.35 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess CORTEX PHARMACEUTIC's long-term financial health and intrinsic value.
CORTEX |
CORTEX PHARMACEUTIC Company Working Capital Analysis
CORTEX PHARMACEUTIC's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current CORTEX PHARMACEUTIC Working Capital | 6.32 M |
Most of CORTEX PHARMACEUTIC's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CORTEX PHARMACEUTIC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionBased on the company's disclosures, CORTEX PHARMACEUTIC has a Working Capital of 6.32 M. This is 102.16% lower than that of the Oil, Gas & Consumable Fuels sector and 99.49% lower than that of the Energy industry. The working capital for all Germany stocks is 99.57% higher than that of the company.
CORTEX Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CORTEX PHARMACEUTIC's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CORTEX PHARMACEUTIC could also be used in its relative valuation, which is a method of valuing CORTEX PHARMACEUTIC by comparing valuation metrics of similar companies.CORTEX PHARMACEUTIC is currently under evaluation in working capital category among its peers.
CORTEX Fundamentals
| Return On Equity | 0.0555 | |||
| Return On Asset | 0.0185 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 182.81 M | |||
| Shares Outstanding | 37.92 M | |||
| Shares Owned By Insiders | 15.10 % | |||
| Shares Owned By Institutions | 69.39 % | |||
| Number Of Shares Shorted | 123.3 K | |||
| Price To Earning | 21.21 X | |||
| Price To Book | 1.31 X | |||
| Price To Sales | 4.58 X | |||
| Revenue | 34.27 M | |||
| Gross Profit | 30.11 M | |||
| EBITDA | 15.32 M | |||
| Net Income | 2.32 M | |||
| Cash And Equivalents | 3.4 M | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 30.2 M | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 1.49 X | |||
| Book Value Per Share | 3.44 X | |||
| Cash Flow From Operations | 18.08 M | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | 0.19 X | |||
| Target Price | 4.35 | |||
| Number Of Employees | 18 | |||
| Beta | 0.064 | |||
| Market Capitalization | 164.96 M | |||
| Total Asset | 163.92 M | |||
| Retained Earnings | 77.07 M | |||
| Working Capital | 6.32 M | |||
| Current Asset | 6.57 M | |||
| Current Liabilities | 4.47 M | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 1.88 % | |||
| Net Asset | 163.92 M | |||
| Last Dividend Paid | 0.15 |
About CORTEX PHARMACEUTIC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CORTEX PHARMACEUTIC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CORTEX PHARMACEUTIC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CORTEX PHARMACEUTIC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in CORTEX Stock
If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |